NIH's flat budget for 2024 will force 'very difficult decisions'

Jocelyn Kaiser

DOI: https://doi.org/10.1126/science.adp4709

IF: 56.9

2024-03-30

Science

Abstract:Belated Senate and House compromise eliminates policy riders restricting certain studies

multidisciplinary sciences

What problem does this paper attempt to address?

Cuts to high-profile NIH efforts leave researchers reeling

Jocelyn Kaiser

DOI: https://doi.org/10.1126/science.adq1773

IF: 56.9

2024-05-03

Science

Abstract:Drop in 21st Century Cures Act funding will slow BRAIN and All of Us projects

multidisciplinary sciences
NIH Portfolio Allocation, Lemmings, and the Silent Spring: A Time-Capsule Commentary & Its Update

Mark Boothby

DOI: https://doi.org/10.12688/f1000research.1-5.v1

2012-07-20

Abstract:With the release of the US President's proposed budget for the Federal Fiscal year (FY) 2013, to start October 1, 2012, we've spun yet again into the mad vortex of an appropriation season. Fundamental re-thinks of how biological and medical research are prioritized and funded are urgently needed, but sadly appear to be unlikely unless the research and advocacy communities push harder and in a more unified manner. Early in the Obama presidency and the NIH Directorship of Dr Francis Collins, the FASEB Office of Public Affairs performed an analysis of trends in funding of R01 and other Research Project Grants and shared that with the Director and his office. Using the FASEB analysis, whose numbers drew on NIH data, an independent commentary (below) was submitted to (but not published in) Science. With the analysis a few years old, this older viewpoint is followed by updates that touch on how the trends have fared since early 2010 and comment on other aspects of the ongoing cull in biomedical research. In particular, data on some of the growth areas that continue to prosper at the expense of the ever-declining direct support for R01 science are discussed.
Biden’s lean science budget doesn’t fund all his priorities

Jeffrey Mervis

DOI: https://doi.org/10.1126/science.adp1969

IF: 56.9

2024-03-15

Science

Abstract:White House faces tight spending cap in 2025 request

multidisciplinary sciences
Major biomedical funder NIH poised for massive reform under Trump 2.0

Max Kozlov

DOI: https://doi.org/10.1038/d41586-024-03736-0

IF: 64.8

2024-11-18

Nature

Abstract:Sweeping changes and more research scrutiny could be on the way for the US National Institutes of Health. Sweeping changes and more research scrutiny could be on the way for the US National Institutes of Health.

multidisciplinary sciences
NIH advisory group pushes for big pay raise for U.S. postdocs

Katie Langin

DOI: https://doi.org/10.1126/science.adn6358

IF: 56.9

2023-12-22

Science

Abstract:Though applauded by many, measure would strain lab budgets if adopted.
Research advocates see 'no good news for science'

Jeffrey Mervis

DOI: https://doi.org/10.1126/science.adu5820

IF: 56.9

2024-11-18

Science

Abstract:Trump agenda and a Republican Congress point to funding cuts and policy shifts

multidisciplinary sciences
U.S. blocks funding for pandemic research group

Jocelyn Kaiser

DOI: https://doi.org/10.1126/science.adq5967

IF: 56.9

2024-05-25

Science

Abstract:EcoHealth Alliance mishandled grant that helped fund virus studies in China, officials say

multidisciplinary sciences
Cutting Science Budget Would Be “neanderthal” Behaviour, Expert Says

Nigel Hawkes

DOI: https://doi.org/10.1136/bmj.h5217

2015-01-01

Abstract:The UK government would be behaving “like Neanderthals” if it cut the science budget sharply in the spending review due in November, the president of the Royal Society, Paul Nurse, told a briefing at the Science Media Centre in London on Tuesday 29 September. Rumours of a 25-40% cut in spending by the Department of Business, Innovation and Skills, which holds the purse strings, have alarmed the science lobby. Nurse said that he did not believe that such deep cuts were contemplated for spending on research and development but that if they happened “they would destroy the scientific endeavour” in the United …
New NIH chief opens up about risky pathogens, postdoc salaries and the year ahead

Max Kozlov

DOI: https://doi.org/10.1038/d41586-024-00086-9

IF: 64.8

2024-01-16

Nature

Abstract:Nature talks to Monica Bertagnolli about hot-button issues and her top priorities for 2024. Nature talks to Monica Bertagnolli about hot-button issues and her top priorities for 2024.

multidisciplinary sciences
Bill targeting Chinese firms worries U.S. researchers

Robert F. Service

DOI: https://doi.org/10.1126/science.adt2248

IF: 56.9

2024-09-21

Science

Abstract:Biosecure Act could hinder science collaborations, limit sequencer purchases

multidisciplinary sciences
Once reluctant, new NIH chief Monica Bertagnolli embraces role

Jocelyn Kaiser

DOI: https://doi.org/10.1126/science.adn8381

IF: 56.9

2024-01-05

Science

Abstract:Improving patient care is top priority for head of world's largest biomedical research funder

multidisciplinary sciences
Rejuvenating American Healthcare

Peter J Pitts

DOI: https://doi.org/10.5912/jcb1018

2022-05-07

Journal of Commercial Biotechnology

Abstract:The debate over overhauling the American healthcare system is stuck on hold and plagued by soundbites. It's time to insert substance and science into the conversation. If we learn nothing else from the COVID-19 experience, it's that when the entire healthcare ecosystem works together to solve a seemingly unsolvable problem (in this case broader access to innovative prescription drugs) ... we can. Nothing less than the future of American healthcare is at stake. During his March 2022 State of the Union Address, President Biden suggested a policy of price controls through direct Medicare negotiation to lower the costs of prescription drugs. This approach has long been discussed in the abstract. Let's examine the details and potential consequences of such a proposition more closely.
The dangerous precedent of censoring scientific dissemination

Jesse D Schold,Timothy L Pruett,Elizabeth A Pomfret,Ty B Dunn

DOI: https://doi.org/10.1016/j.ajt.2024.09.002

2024-09-07

Abstract:The American Transplant Congress (ATC) is the largest national transplant meeting in the United States jointly sponsored by the American Society of Transplantation and the American Society of Transplant Surgeons. The 2024 ATC was held in Philadelphia, Pennsylvania during which a number of peer-reviewed scientific abstracts were censored from the program by the Health Resources and Services Administration. These abstract presentations were redacted from the program for perceived conflict with current government policy effectively restricting dissemination of highly rated findings and discussion in a scientific forum. In this viewpoint, we describe the content of the abstracts that were withdrawn from the annual ATC meeting and the implications of this censorship by the Health Resources and Services Administration. We further consider the ramifications of this action for the prospective evaluation of government policy and the relationship of the contract agency with the transplant community in the context of ongoing discussions of modernizing the transplant system which has previously been critiqued for lack of transparency.
U.S. agency funding for climate and health research falls short

Meredith Wadman

DOI: https://doi.org/10.1126/science.ads6027

IF: 56.9

2024-08-25

Science

Abstract:Interdisciplinary teams struggle to find a home in siloed federal grant-funding system

multidisciplinary sciences
Taxpayers' Share of US Prescription Drug and Insulin Costs: a Cross-Sectional Study

Elizabeth Schrier,David U. Himmelstein,Adam Gaffney,Danny McCormick,Steffie Woolhandler

DOI: https://doi.org/10.1007/s11606-024-09032-x

IF: 5.7

2024-10-26

Journal of General Internal Medicine

Abstract:Drug prices affect government budgets directly through spending on public programs like Medicare and Medicaid, and indirectly via private coverage for public employees and tax subsidies for private insurance. Yet, the Senate parliamentarian ruled that the Senate could not use streamlined Budget Reconciliation to extend the Inflation Reduction Act's controls on insulin co-payment or drug prices to private insurers on the grounds that their expenditures do not affect the federal budget.

medicine, general & internal,health care sciences & services
Any Foreseeable Growth in Nhs Will "feel Like A Cut" Because of Demographics and Cost Inflation, Report Says

Nigel Hawkes

DOI: https://doi.org/10.1136/bmj.e4587

2012-01-01

British Medical Journal

Abstract:The NHS in England faces a decade of austerity, and a squeeze on spending is likely to last at least until 2021-2, concludes a new analysis commissioned by the Nuffield Trust and carried out by the Institute for Fiscal Studies.1 In spite of the relative protection given to health spending by the government, demographic changes and cost inflation mean that under almost any imaginable scenario the NHS budget will rise more slowly than the likely demand. The immediate challenge of making £15bn (€20bn; $24bn) to £20bn of savings in four years during this parliament—the tightest four year period of funding for the NHS in the past half century—will continue into the next four years. “If NHS productivity does not increase sufficiently fast to bridge the gap between funding and demand pressures, then access to and quality of care is likely to deteriorate,” the report says. “Serious thought must …
Publish, Don’t Perish: Recommendations for Mitigating Impacts of the New Federal Open Access Policy

Alexander B. Belles,Karen E. Beatty,Claire H. Rodman,Charles J. Connolly

DOI: https://doi.org/10.38126/jspg220101

2023-03-06

Journal of Science Policy & Governance

Abstract:In August, the White House Office of Science and Technology Policy issued a new policy requiring that all federally funded scholarly research be accessible to the public immediately upon publication. While this open access policy will ultimately benefit society by increasing the availability of data and research outputs, it could place a heavy burden on researchers due to the relatively high cost of open access alongside an academic culture that tends to favor publishing in high impact subscription journals. We examine the complexities of the traditional publishing landscape and offer recommendations for agencies, universities, and publishers to mitigate the impacts on researchers. Specifically, we recommend a short-term increase in funding to cover higher publishing costs, but contributions from all stakeholders are needed to facilitate a long-term solution.
Trump nominates Jay Bhattacharya to head US National Institutes of Health

Janice Hopkins Tanne

DOI: https://doi.org/10.1136/bmj.q2695

2024-12-03

BMJ

Abstract:President elect Donald Trump said he would nominate Jay Bhattacharya, who opposed lockdowns during the covid-19 pandemic, to head the National Institutes of Health (NIH). Like other Trump nominations he will need confirmation by the Senate to assume his position in January, when Trump takes office.Trump said on social media, "Together, Jay and RFK Jr will restore the NIH to a Gold Standard of Medical Research as they examine the causes of, and solutions to, America's biggest health challenges, including our Crisis of Chronic Illness and Disease."1The NIH is part of the Department of Health and Human Services, which Trump has nominated Robert F Kennedy Jr to head.2 Kennedy is sceptical of vaccines and has indicated he would like to direct NIH to focus on chronic diseases.NIH has a budget of about $48bn (£38bn; €46bn) and supports research through its 27 separate institutes and centres that focus on different diseases....

medicine, general & internal
National Institutes of Health Funding for Surgeon-Scientists in the US

Lindsay A. Demblowski,Seth M. Steinberg,Rebecca A. Meseroll,George M. Santangelo,Martha A. Zeiger

DOI: https://doi.org/10.1001/jamasurg.2023.7167

2024-03-14

JAMA Surgery

Abstract:This Special Communication provides an update on the status of surgeons funded by the National Institutes of Health for fiscal year 2022.

surgery
Large Publication Gap for Gynecologic Cancers in High–Impact Factor Journals

Nikita Sinha,Amanda McDonald,Danika Barry,Emma L. Barber

DOI: https://doi.org/10.1097/aog.0000000000005301

2023-08-23

Obstetrics and Gynecology

Abstract:The Cancer Moonshot Initiative was reignited in 2022 to accelerate the rate of progress against cancer. 1 This ambitious research and policy initiative was originally announced in 2016, authorizing $1.8 billion in funding for cancer research over the subsequent 7 years. 1 Despite these increases in the National Cancer Institute (NCI) research budget, the NCI has seen a consistent decrease in its budget when inflation-adjusted dollars are used. 2 This stagnant funding makes it difficult to maintain the pace of scientific discovery and to continue progress against cancer, which can be seen in the substantial decrease in new research proposals funded and number of fully funded National Institutes of Health studies. 3

obstetrics & gynecology

NIH's flat budget for 2024 will force 'very difficult decisions'

Cuts to high-profile NIH efforts leave researchers reeling

NIH Portfolio Allocation, Lemmings, and the Silent Spring: A Time-Capsule Commentary & Its Update

Biden’s lean science budget doesn’t fund all his priorities

Major biomedical funder NIH poised for massive reform under Trump 2.0

NIH advisory group pushes for big pay raise for U.S. postdocs

Research advocates see 'no good news for science'

U.S. blocks funding for pandemic research group

Cutting Science Budget Would Be “neanderthal” Behaviour, Expert Says

New NIH chief opens up about risky pathogens, postdoc salaries and the year ahead

Bill targeting Chinese firms worries U.S. researchers

Once reluctant, new NIH chief Monica Bertagnolli embraces role

Rejuvenating American Healthcare

The dangerous precedent of censoring scientific dissemination

U.S. agency funding for climate and health research falls short

Taxpayers' Share of US Prescription Drug and Insulin Costs: a Cross-Sectional Study

Any Foreseeable Growth in Nhs Will "feel Like A Cut" Because of Demographics and Cost Inflation, Report Says

Publish, Don’t Perish: Recommendations for Mitigating Impacts of the New Federal Open Access Policy

Trump nominates Jay Bhattacharya to head US National Institutes of Health

National Institutes of Health Funding for Surgeon-Scientists in the US

Large Publication Gap for Gynecologic Cancers in High–Impact Factor Journals